Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment

Background and aims Inappropriate immune responses contribute to the continuous stimulation of the intestinal immune system in chronic inflammatory bowel disease (IBD). Among several pathogenic factors, a numerical deficiency of regulatory T (Treg) cells has been suggested to lead to an insufficient compensation of chronically activated T lymphocytes. This study was conducted to investigate whether increased apoptosis contributes to Treg cell deficiency in IBD and whether successful treatment with antitumour necrosis factor α (TNFα) is achieved by reducing of Treg cell apoptosis. Methods Apoptosis of CD4+Foxp3+ Treg cells in tissue sections of patients with active IBD was analysed by immunohistochemistry and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labelling) staining. Apoptosis of peripheral blood CD4+CD25+Foxp3+ Treg cells was investigated by flow cytometry and annexin-V staining. In addition, caspase activity and apoptosis were measured in sera of patients with IBD treated with anti-TNFα by a luminometric caspase enzyme assay. Results It is demonstrated that patients with active IBD revealed increased apoptosis of local CD4+Foxp3+ Treg cells in the inflamed mucosa compared with non-inflamed control colon tissue. Moreover, in peripheral blood a reduced frequency and increased apoptosis of Treg cells were found and accompanied by elevated caspase activity in the serum. During anti-TNFα treatment, Treg cell apoptosis declined in close correlation with elevated peripheral Treg cell numbers and a decrease of caspase activation and disease activity. Conclusions These data suggest that increased apoptosis of Treg cells plays a potentially important role in the pathogenesis of IBD and can be reversed by anti-TNFα treatment. Measurement of Treg cell apoptosis and serum caspase activity might therefore represent promising tools for monitoring disease activity and treatment response in patients with IBD.

[1]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[2]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[3]  P. Rutgeerts,et al.  Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab† , 2010, Inflammatory bowel diseases.

[4]  F. Powrie,et al.  Regulatory T cells reinforce intestinal homeostasis. , 2009, Immunity.

[5]  Paul Rutgeerts,et al.  Biological therapies for inflammatory bowel diseases. , 2009, Gastroenterology.

[6]  F. Powrie,et al.  Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.

[7]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[8]  D. McKay,et al.  Transient Local Depletion of Foxp3+ Regulatory T Cells during Recovery from Colitis via Fas/Fas Ligand-Induced Death1 , 2008, The Journal of Immunology.

[9]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[10]  Qizhi Tang,et al.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.

[11]  S. Keshav.  Faculty Opinions recommendation of Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. , 2007 .

[12]  K. Papadakis,et al.  Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. , 2007, Clinical immunology.

[13]  P. Krammer,et al.  Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis1 , 2007, The Journal of Immunology.

[14]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[15]  K. Papadakis,et al.  Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis , 2007, Inflammatory bowel diseases.

[16]  N. Amariglio,et al.  α1β1 Integrin+ and Regulatory Foxp3+ T Cells Constitute Two Functionally Distinct Human CD4+ T Cell Subsets Oppositely Modulated by TNFα Blockade1 , 2007, The Journal of Immunology.

[17]  N. Amariglio,et al.  alpha1beta1 Integrin+ and regulatory Foxp3+ T cells constitute two functionally distinct human CD4+ T cell subsets oppositely modulated by TNFalpha blockade. , 2007, Journal of Immunology.

[18]  P. Lipsky,et al.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.

[19]  F. Autschbach,et al.  CD4+CD25+ cell depletion from the normal CD4+ T cell pool prevents tolerance toward the intestinal flora and leads to chronic colitis in immunodeficient mice , 2006, Inflammatory bowel diseases.

[20]  H. Nawata,et al.  An Inverse Correlation of Human Peripheral Blood Regulatory T Cell Frequency with the Disease Activity of Ulcerative Colitis , 2006, Digestive Diseases and Sciences.

[21]  M. Manns,et al.  The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum , 2005, Hepatology.

[22]  T. Giese,et al.  Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.

[23]  I. Rosner,et al.  Increased Spontaneous Apoptosis of CD4+CD25+ T Cells in Patients with Active Rheumatoid Arthritis Is Reduced by Infliximab , 2005, Annals of the New York Academy of Sciences.

[24]  T. Giese,et al.  Regulatory CD4+CD25+ cells reverse imbalances in the T cell pool of bone marrow transplanted TGε26 mice leading to the prevention of colitis , 2005, Gut.

[25]  M. Manns,et al.  Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury , 2004, Hepatology.

[26]  J. Jacobberger,et al.  Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis , 2004, Gut.

[27]  Tetsuya Nakamura,et al.  CD4+CD25bright T Cells in Human Intestinal Lamina Propria as Regulatory Cells1 , 2004, The Journal of Immunology.

[28]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[29]  D. Vergani,et al.  Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. , 2004, Journal of hepatology.

[30]  S. Simpson,et al.  Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery. , 2004, Gastroenterology.

[31]  F. Powrie,et al.  Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.

[32]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[33]  Nigel J. Saunders,et al.  CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms , 2003, The Journal of experimental medicine.

[34]  K. Schulze-Osthoff,et al.  Many cuts to ruin: a comprehensive update of caspase substrates , 2003, Cell Death and Differentiation.

[35]  S. Mohr,et al.  Critical role of caspases in the regulation of apoptosis and proliferation of mucosal T cells. , 2002, Gastroenterology.

[36]  C. Poremba,et al.  Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection , 2001, Hepatology.

[37]  R. Sartor,et al.  Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. , 2001, Gastroenterology.

[38]  Sten Orrenius,et al.  Caspases: their intracellular localization and translocation during apoptosis , 1999, Cell Death and Differentiation.

[39]  E. Shevach,et al.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. , 1998, Journal of immunology.

[40]  R. Testi,et al.  Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. , 1996, The Journal of clinical investigation.

[41]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[42]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[43]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.